194 related articles for article (PubMed ID: 34624451)
1. Impact of the ileal microbiota on colon cancer.
Roberti MP; Rauber C; Kroemer G; Zitvogel L
Semin Cancer Biol; 2022 Nov; 86(Pt 2):955-966. PubMed ID: 34624451
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer.
Roberti MP; Yonekura S; Duong CPM; Picard M; Ferrere G; Tidjani Alou M; Rauber C; Iebba V; Lehmann CHK; Amon L; Dudziak D; Derosa L; Routy B; Flament C; Richard C; Daillère R; Fluckiger A; Van Seuningen I; Chamaillard M; Vincent A; Kourula S; Opolon P; Ly P; Pizzato E; Becharef S; Paillet J; Klein C; Marliot F; Pietrantonio F; Benoist S; Scoazec JY; Dartigues P; Hollebecque A; Malka D; Pagès F; Galon J; Gomperts Boneca I; Lepage P; Ryffel B; Raoult D; Eggermont A; Vanden Berghe T; Ghiringhelli F; Vandenabeele P; Kroemer G; Zitvogel L
Nat Med; 2020 Jun; 26(6):919-931. PubMed ID: 32451498
[TBL] [Abstract][Full Text] [Related]
3. Turning tolerogenic into immunogenic ileal cell death through ileal microbiota: the key to unlock the mystery of colon cancer immunoscore?
Roberti MP; Picard M; Yonekura S; Zitvogel L
Oncoimmunology; 2020 Jun; 9(1):1778834. PubMed ID: 32923141
[TBL] [Abstract][Full Text] [Related]
4. Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota.
Fidelle M; Yonekura S; Picard M; Cogdill A; Hollebecque A; Roberti MP; Zitvogel L
Front Immunol; 2020; 11():600886. PubMed ID: 33381121
[TBL] [Abstract][Full Text] [Related]
5. Microbiome Conundrum in Colon Cancer: Development, Progression, and Therapeutics.
Malla RR
Crit Rev Oncog; 2020; 25(2):129-139. PubMed ID: 33389862
[TBL] [Abstract][Full Text] [Related]
6. The gut microbiome and melanoma: A review.
Makaranka S; Scutt F; Frixou M; Wensley KE; Sharma R; Greenhowe J
Exp Dermatol; 2022 Sep; 31(9):1292-1301. PubMed ID: 35793428
[TBL] [Abstract][Full Text] [Related]
7. Site-specific programming of the host epithelial transcriptome by the gut microbiota.
Sommer F; Nookaew I; Sommer N; Fogelstrand P; Bäckhed F
Genome Biol; 2015 Mar; 16(1):62. PubMed ID: 25887251
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.
Lu Y; Yuan X; Wang M; He Z; Li H; Wang J; Li Q
J Hematol Oncol; 2022 Apr; 15(1):47. PubMed ID: 35488243
[TBL] [Abstract][Full Text] [Related]
9. Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients.
Picard M; Yonekura S; Slowicka K; Petta I; Rauber C; Routy B; Richard C; Iebba V; Tidjani Alou M; Becharef S; Ly P; Pizzato E; Lehmann CHK; Amon L; Klein C; Opolon P; Gomperts Boneca I; Scoazec JY; Hollebecque A; Malka D; Ghiringhelli F; Dudziak D; Berx G; Vereecke L; van Loo G; Kroemer G; Zitvogel L; Roberti MP
Cell Death Differ; 2021 May; 28(5):1532-1547. PubMed ID: 33262469
[TBL] [Abstract][Full Text] [Related]
10. The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges.
Bouferraa Y; Chedid A; Amhaz G; El Lakkiss A; Mukherji D; Temraz S; Shamseddine A
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360802
[TBL] [Abstract][Full Text] [Related]
11. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
Boesch M; Horvath L; Baty F; Pircher A; Wolf D; Spahn S; Straussman R; Tilg H; Brutsche MH
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36343977
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal Microbiota and Colon Cancer.
Hold GL
Dig Dis; 2016; 34(3):244-50. PubMed ID: 27028619
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications.
Zhang L; Xiang Y; Li Y; Zhang J
Front Immunol; 2022; 13():1058272. PubMed ID: 36569873
[TBL] [Abstract][Full Text] [Related]
14. The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research.
McKenzie ND; Hong H; Ahmad S; Holloway RW
Crit Rev Oncol Hematol; 2021 Jan; 157():103165. PubMed ID: 33227575
[TBL] [Abstract][Full Text] [Related]
15. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition.
Guardamagna M; Berciano-Guerrero MA; Villaescusa-González B; Perez-Ruiz E; Oliver J; Lavado-Valenzuela R; Rueda-Dominguez A; Barragán I; Queipo-Ortuño MI
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233289
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiome and cancer immunotherapy.
Li W; Deng Y; Chu Q; Zhang P
Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
[TBL] [Abstract][Full Text] [Related]
18. Spatial heterogeneity of bacterial colonization across different gut segments following inter-species microbiota transplantation.
Li N; Zuo B; Huang S; Zeng B; Han D; Li T; Liu T; Wu Z; Wei H; Zhao J; Wang J
Microbiome; 2020 Nov; 8(1):161. PubMed ID: 33208178
[TBL] [Abstract][Full Text] [Related]
19. Emerging roles of the gut microbiota in cancer immunotherapy.
Shi Z; Li H; Song W; Zhou Z; Li Z; Zhang M
Front Immunol; 2023; 14():1139821. PubMed ID: 36911704
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
Front Immunol; 2020; 11():612202. PubMed ID: 33488618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
